Biovail’s Aplenzin Wins FDA Go-ahead
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm chalks up good news on antidepressant after plenty of bad.
You may also be interested in...
Prestwick Buyout Scores Huntington’s Drug For Biovail
Canadian company affirms prior deal that gave Ovation the U.S. rights to Xenazine.
Prestwick Buyout Scores Huntington’s Drug For Biovail
Canadian company affirms prior deal that gave Ovation the U.S. rights to Xenazine.
Lilly Wins Fibromyalgia Management Indication For Cymbalta
The blockbuster SNRI is second into the fibromyalgia space, following Pfizer’s Lyrica.